Announcements Trials
Browse Landscape

Phase

Phase 1 8Phase 2 4Phase 1/2 1

Status

Unknown 2Completed 2

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 2Plasma cell 1Other hematologic neoplasm 1Gastrointestinal 1

Conditions

Lymphoma, T-Cell, Peripheral 2Multiple Myeloma 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma 1Hematologic Neoplasms 1Carcinoma, Hepatocellular 1Bone Marrow Neoplasms 1

Interventions

Carboplatin 273Paclitaxel 267Gemcitabine 244Bevacizumab 226Cisplatin 218pembrolizumab 214Docetaxel 210Pemetrexed 162Capecitabine 148Fluorouracil 129Oxaliplatin 121Cyclophosphamide 121Nivolumab 112Dexamethasone 100Trastuzumab 89Leucovorin 87Cetuximab 85Rituximab 83Irinotecan 82Injections 81Erlotinib Hydrochloride 70Prednisone 68Doxorubicin 68Temozolomide 67atezolizumab 65Bortezomib 65Ipilimumab 64Fulvestrant 59Radiotherapy 54Drug Therapy 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × INDUSTRY × darinaparsin × Clear all
NCT02653976 2024-01-26

A Phase 2 Study of SP-02L in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Solasia Pharma K.K.

Phase 2 Completed
67 enrolled 13 charts
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT00423306 2013-11-14

A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma

Alaunos Therapeutics

Phase 2 Unknown
15 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00423644 2013-11-14

A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b

Alaunos Therapeutics

Phase 2 Unknown
17 enrolled
Plasma cell

Multiple Myeloma

NCT00421213 2012-07-19

Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers

Alaunos Therapeutics

Phase 2 Completed
50 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Bone Marrow Neoplasms, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡